6. Provigil - Top 10 Warnings and Recalls
Drug: Provigil
2006 sales: $727 million
Manufacturer: Cephalon
Safety concern: Warning; Stevens-Johnson syndrome, psychiatric problems
Related Articles:
> FDA warns of Provigil risks. Report
> Cephalon shares tank after Sparlon (Provigil) rejection. Report
> FDA staffers question safety of Provigil for ADHD. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: